Endometrial cancer: a review and current management strategies: part II.
about
Molecular cues on obesity signals, tumor markers and endometrial cancer.Antiprogestins in gynecological diseases.Whole Genome Pathway Analysis Identifies an Association of Cadmium Response Gene Loss with Copy Number Variation in Mutant p53 Bearing Uterine Endometrial Carcinomas.Are preoperative histology and MRI useful for classification of endometrial cancer risk?The sL1CAM in sera of patients with endometrial and ovarian cancers.Sentinel Lymph Node Mapping in Patients with Endometrial Carcinoma: Less Can Be More.Clinical translation for endometrial cancer stem cells hypothesis.An update on the current pharmacotherapy for endometrial cancer.The clinical management of inoperable endometrial carcinoma.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancerDual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma.Quality of Cancer Surveillance Clinical Practice Guidelines: Specificity and Consistency of Recommendations.Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review.Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.Intraoperative Pathologic Consultation on Hysterectomy Specimens for Endometrial Cancer: An Assessment of the Accuracy of Frozen Sections, "Gross-Only" Evaluations, and Obtaining Random Sections of a Grossly "Normal" Endometrium.Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer.Frequency of endometrial cancer and atypical hyperplasia in infertile women undergoing hysteroscopic polypectomy.Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.Clinical Behavior and Treatment of Endometrial Cancer.Carbon-ion radiotherapy for inoperable endometrial carcinoma.Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.Endometrial cancer in an increasingly obese population: Exploring alternative options when surgery may not cut it.α-Chaconine and α-Solanine Inhibit RL95-2 Endometrium Cancer Cell Proliferation by Reducing Expression of Akt (Ser473) and ERα (Ser167).Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells
P2860
Q30372789-D070CA15-CC68-4805-B36F-62A89B61C7CFQ34587636-0F745AE0-CAEC-4C49-80DC-A9745E952A22Q36071143-353A7999-7127-4A31-B243-9042DDE84298Q36080667-D04D5E7A-A711-4075-9171-04AD25C725DEQ37578356-C1AEFCA1-F5C6-4D75-9F67-DE076CE27B18Q38431386-C124ACB9-6809-45A4-8B71-10649D14735BQ38557171-2E1F70C2-13CD-4D78-A067-45D82B8313A9Q38656675-C53EAA03-B7C5-4FD5-BC31-B49765E0E79CQ38783340-E838152A-0120-4334-8297-92CCAFB02C72Q38788210-9BCF881A-D1CE-4E65-85D6-0662025503E8Q39069570-1A0DFC70-C432-447E-9078-08D78324CA6AQ39808566-94640BA3-2766-43CA-9FA8-DC28B3F08B50Q41099951-73437EE1-4940-4B30-AA72-617C5FE8C06CQ41375155-5F0A423B-89CF-46E0-9B12-88E85FFA1A0CQ41500426-73648270-580B-4540-B3FE-A68C6B2B52F6Q42090449-F025400F-1F70-48AD-B2C6-1868A722120DQ42371820-324B836F-96C8-4AFC-9ACE-DEFAD10BD429Q46785812-F028320D-7422-40E8-8FB9-58FDF7459467Q47240983-EC395F2E-684B-4BDA-B7C6-AFB4A9C3DC32Q48124618-AA540F51-A967-41FE-8546-008CBD58BF79Q49293517-3D410BE0-7B66-4EC7-867A-E2E8894F8E09Q51771970-9634B104-D84F-4AF9-8ED4-20D1F6FB8A5FQ52611832-AB66A468-2ACF-42BA-AD4D-83909CC87A04Q53104142-9CAD8E9B-D8DD-4D52-81BC-F88B7E36D08FQ54011680-D4F9996C-8E32-49FA-B3B3-53A84D0E295CQ54977406-797950BF-6374-4A22-946A-F56702EB8D51Q55261133-381C2C6B-7BC9-45AE-8D4B-B3656E46CFAAQ55417923-15C876CB-E741-4052-911C-B565BE020178Q55498690-A67AE7AF-D3D0-4FB8-9E28-DDDC6FAB22FCQ58769245-691763DF-ABC6-47B6-B412-3DDD9093B469
P2860
Endometrial cancer: a review and current management strategies: part II.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Endometrial cancer: a review and current management strategies: part II.
@en
type
label
Endometrial cancer: a review and current management strategies: part II.
@en
prefLabel
Endometrial cancer: a review and current management strategies: part II.
@en
P2093
P1433
P1476
Endometrial cancer: a review and current management strategies: part II.
@en
P2093
Alexander B Olawaiye
Emery Salom
Fadi Abu Shahin
Mario Leitao
Molly Brewer
Paola Gehrig
SGO Clinical Practice Endometrial Cancer Working Group
Society of Gynecologic Oncology Clinical Practice Committee
Thomas J Herzog
P304
P356
10.1016/J.YGYNO.2014.06.003
P407
P50
P577
2014-06-11T00:00:00Z